GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $257,000 | -1.2% | 5,903 | +0.2% | 0.06% | 0.0% |
| Q4 2021 | $260,000 | +16.1% | 5,889 | +0.2% | 0.06% | 0.0% |
| Q3 2021 | $224,000 | -3.9% | 5,875 | +0.2% | 0.06% | -4.8% |
| Q2 2021 | $233,000 | +1.3% | 5,861 | -8.9% | 0.06% | -8.7% |
| Q1 2021 | $230,000 | -15.4% | 6,435 | -12.9% | 0.07% | -22.5% |
| Q4 2020 | $272,000 | -26.7% | 7,385 | -33.4% | 0.09% | -36.4% |
| Q3 2020 | $371,000 | -27.5% | 11,090 | -11.6% | 0.14% | -32.4% |
| Q2 2020 | $512,000 | -6.9% | 12,548 | -2.7% | 0.21% | -14.5% |
| Q1 2020 | $550,000 | -23.1% | 12,900 | -15.3% | 0.24% | -7.6% |
| Q4 2019 | $715,000 | +13.0% | 15,224 | +2.7% | 0.26% | -47.0% |
| Q3 2019 | $633,000 | -5.7% | 14,829 | -11.6% | 0.49% | -8.7% |
| Q2 2019 | $671,000 | -12.5% | 16,771 | -8.6% | 0.54% | -17.0% |
| Q1 2019 | $767,000 | +10.5% | 18,349 | +1.0% | 0.65% | -2.7% |
| Q4 2018 | $694,000 | – | 18,161 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |